Ashland Global Holdings Inc logo

Ashland Global Holdings Inc(ASH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 17 days
PROFIT SINCE LAST BUY
+3.94% ▲
LAST CLOSE
$76.47
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ASH

11/13/2026: ASH (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Ashland Global Holdings Inc is a specialty chemical company that supplies high-performance additives and ingredients to pharmaceutical, personal care, and industrial markets. The company benefits from a solid portfolio of sticky, high-margin life sciences products and strong formulation expertise, though its earnings remain sensitive to periodic inventory destocking cycles. Its primary investment story centers on expanding high-value offerings in pharmaceutical delivery and sustainable solutions. Key risks include raw material inflation and intense competition from larger chemical enterprises. The stock is best suited for value and dividend-oriented investors who can monitor cyclical demand trends and pharmaceutical segment execution.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitOrganic growth tends to track modest end-market expansion rates rather than explosive hyper-growth.
Momentum investorStrong fit while signal remains positiveMomentum appeal depends closely on favorable intermediate earnings breakouts and positive sector sentiment shifts.
Value investorStrong fitThe stock often trades at reasonable valuation multiples relative to its asset-light specialty chemical peers.
Dividend investorStrong fitAshland provides a steady and reliable dividend payout history backed by stable cash generation.
Low-risk investorMixed fitWhile lower beta than cyclical commodity chemical peers, it remains exposed to raw material and industrial demand swings.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMediumThe stock demonstrates lower market beta than broader indices but reacts to cyclical chemical sentiment.
Valuation riskLowShares typically trade at reasonable multiples that limit excessive downside revaluation risk.
Competition risk (specialty formulation competition)Medium / highIntense competition from global chemical giants requires continuous R&D investment to maintain margins.
Business qualityStrongProprietary specialty formulations and long-standing pharma customer qualifications provide solid business resilience.
Dividend incomeLowPayouts are well-supported by free cash flows, offering dependable income for shareholders.
Execution riskMediumSuccessful commercialization of new specialty products and cost-savings programs is vital for earnings expansion.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.50B USD
Price to earnings Ratio 139.04
1Y Target Price 82.45
Price to earnings Ratio 139.04
1Y Target Price 82.45
Volume (30-day avg) 675.8K shares
Beta 0.36
52 Weeks Range 46.69 - 79.50
Updated Date 11/15/2026
52 Weeks Range 46.69 - 79.50
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.55

Sector & Industry Intelligence

Sector

Basic Materials

Defensive
Sentiment
Bearish
Momentum
Momentum Steady
BUY participation
23.1%
Active BUY / eligible
9 / 39
30-Day BUY Count Change
+2
Market state
Bearish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Specialty Chemicals

BUY participation
57.1%
Active BUY / eligible
4 / 7
30-Day BUY Count Change
+1

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit 11.56%
Avg. Invested days 46
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
ASH receives a 3-star rating, supported by solid company fundamentals, and solid analyst coverage. The rating is constrained by weak price momentum, and limited analyst upside.

Company Fundamentals

★★★★★
ASH has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2026 versus FY2025, strong earnings growth (+100.5%) and solid cash generation (FCF margin 13.5%) are partially offset by moderate revenue growth (+2.1%), soft profitability (net margin 0.2%), modest insider ownership of 1.57%.

Financial Health Rating

★★★★★
ASH's financial health is supported by solid cash strength, including free-cash-flow generation (13.5% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is ASH's strongest growth driver at +6375.0% FY2026 versus FY2025 (strong, 5 stars). By comparison, earnings growth (+100.5%, strong) is also strong, while revenue growth (+2.1%, moderate) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 115.0% and approximately 82.9% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 1.57% provides only moderate management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 12.47%
40 North Industries LLC 9.88%
Franklin Templeton Inc 7.90%
Dimensional Fund Advisors, Inc. 5.74%
Vanguard Portfolio Management, LLC 5.38%

Unit Economics (Per $1K Revenue)

★★★★★
ASH generates approximately $323 of gross profit, $56 of operating income, and $135 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Soft margins and solid cash conversion support a 3-star rating, while capital efficiency is weak.

Economic Dimensions

★★★★★
Effective Tax Rate: 63.77%

Quantitative Style Profile

★★★★★
ASH has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Life SciencesExcipients, binders, and controlled-release polymers for pharmaceuticals and nutrition.This is a high-margin, sticky revenue stream because pharmaceutical products require lengthy regulatory approvals.
Personal CareSpecialty polymers and ingredients for skin, hair, and home care products.Provides stable consumer-linked cash flows tied to everyday personal hygiene and cosmetic trends.
Specialty AdditivesRheology modifiers and thickeners for architectural coatings and construction applications.Tied closely to commercial and residential construction cycles and paint demand.
GeographyGlobal manufacturing, sales, and distribution across the Americas, EMEA, and Asia-Pacific.Provides geographic diversification but exposes earnings to foreign currency fluctuations and regional economic shifts.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-03
When After Market
Estimate 1.3
Actual 1.12

Profitability

Profit Margin 0.22%
Operating Margin (TTM) 6.07%

Management Effectiveness

Return on Assets (TTM) 1.55%
Return on Equity (TTM) 1.33%

Valuation

Trailing PE 139.04
Forward PE 18.42
Enterprise Value 4.49B
Price to Sales(TTM) 1.88
Enterprise Value 4.49B
Price to Sales(TTM) 1.88
Enterprise Value to Revenue 2.41
Enterprise Value to EBITDA 15.29
Shares Outstanding 45.79M
Shares Floating 37.95M
Shares Outstanding 45.79M
Shares Floating 37.95M
Percent Insiders 1.57
Percent Institutions 115.05

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.